📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Enovis Corp

Common Name
Enovis
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
7,367
Ticker
ENOV
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Enovis Corporation is a diversified healthcare equipment company focused on developing and supplying a broad range of innovative medical technology solutions. The primary function of the company is to...

Enovis's GHG Emissions Data Preview

In 2024, Enovis completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Enovis has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=ENOV&reporting_period=2024"

Verified Sources Behind Enovis’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Enovis’s data sources below and access millions more through our Disclosure Search.

a. Enovis's CSR Report 2024
a. Enovis's CSR Report 2024

Insights into Enovis's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions ofEnovis amounted to18,946.6metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Enovisincreased by 35.39%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Enovis's Scope 1 Emissions Over Time

2023202406001.2 k1.8 k2.4 ktCO2e+19%
  • Total Scope 1
  • Year-over-Year Change

What are Enovis's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Enovis were 2,321 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Compared to the previous year(2023), Enovis's Scope 1 emissions increased by 19.01%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Enovis's Scope 2 emissions?

In 2024, Enovis reported Scope 2 greenhouse gas (GHG) emissions of 16,625.6 tCOâ‚‚e using the market-based method.a

Has Enovis reduced its Scope 2 emissions over time?

Compared to the previous year(2023), Enovis's Scope 2 emissions(Market-Based) rose by 38.04% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Enovis use for Scope 2 reporting?

In 2024, Enovis reported its Scope 2 emissions using the market-based method.a

Enovis's Scope 2 Emissions Over Time

2023202404.5 k9 k13.5 k18 ktCO2e
  • Total Scope 2 Market-Based

Insights into Enovis’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Enovis reported Scope 1 greenhouse gas (GHG) emissions of 2,321 tCOâ‚‚e and total revenues of USD 2,108 millions. This translates into an emissions intensity of 1.1 tCOâ‚‚e per millions USD.a

Enovis's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)ARIInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MAAAmneal PharmaceuticalsYear: 2024Scope 1: 40,500 tCO2eRevenue: $M 2,794Scope 1 Intensity: 14.50 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MAlignment HealthcareYear: 2024Scope 1: 130 tCO2eRevenue: $M 2,703Scope 1 Intensity: 0.05 tCO2e/$MRRRevvityYear: 2024Scope 1: 2,468 tCO2eRevenue: $M 2,755Scope 1 Intensity: 0.90 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$M

How does Enovis's GHG emissions intensity compare to its peers?

In 2024, Enovis reported a Scope 1 emissions intensity of 1.1 tCOâ‚‚e per millions USD. Compared to the peer group median of 2.68, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Enovis rank on GHG emissions intensity within its industry?

In 2024, Enovis ranked 5 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Enovis among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Enovis's GHG Emissions Dataset?
Sign Up